BioSpace News Archive

Asher Biotherapeutics today announced that it will present two abstracts at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC 2021), being held in Washington D.C. and virtually, November 10-14, 2021.

Align Technology, Inc. announced today that the Company will report third quarter 2021 financial results on Wednesday, October 27, 2021, after the close of market.

ADMA Biologics, Inc. today announced an exclusive educational event at IDWeek 2021 on respiratory viral infections, presented by nationally recognized clinical experts Dr. Michael Ison from Northwestern University and Dr. Jolan Walter from the University of South Florida and Johns Hopkins All Children’s Hospital.

REGENXBIO Inc. (Nasdaq: RGNX) today announced that data from the RGX-314 clinical trials will be presented in three oral presentations at the American Society of Retina Specialists Annual Meeting taking place in San Antonio, TX, from October 8 to 12, 2021.

Teams at IDEX business units across the United States now have expanded opportunities to volunteer locally as part of a new partnership between Boys & Girls Clubs of America and the IDEX Foundation, the charitable giving extension of IDEX Corporation (NYSE: IEX).

AnPac Bio-Medical Science Co., Ltd. announced today its unaudited financial results for the six months ended June 30, 2021.

Inari Medical, Inc., a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced the appointment of Mr. Dana G. Mead, Jr. to its board of directors.

Bolt Biotherapeutics, Inc. announced that it will be presenting three abstracts at the 2021 Society for Immunotherapy of Cancer’s 36th Annual Meeting, which is being held from Nov. 10-14, both virtually and in person in Washington, D.C.

Timber Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, announced that it is presenting at the European Academy of Dermatology and Venereology’s 30th anniversary congress being held virtually from September 29-October 2, 2021.

Fate Therapeutics, Inc. (NASDAQ: FATE), today announced that one oral and four poster presentations for the Company’s induced pluripotent stem cell (iPSC) product platform were accepted for presentation at the 36th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) being held November 10-14, 2021.